本页面由Tiger Trade Technology Pte. Ltd.提供服务

Artelo Biosciences, Inc.

0.6920
-0.0204-2.86%
盘后0.6815-0.0105-1.52%19:09 EDT
成交量:10.89万
成交额:7.70万
市值:317.98万
市盈率:-0.06
高:0.7300
开:0.7200
低:0.6803
收:0.7124
52周最高:28.98
52周最低:0.6803
股本:459.51万
流通股本:435.32万
量比:0.07
换手率:2.50%
股息:- -
股息率:- -
每股收益(TTM):-11.3794
每股收益(LYR):-37.5481
净资产收益率:-705.71%
总资产收益率:-127.92%
市净率:0.64
市盈率(LYR):-0.02

数据加载中...

2026/08/21

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/17

重要事件披露

Form 8-K - Current report
2026/05/27

重要事件披露

Form 8-K - Current report
2026/05/16

SEC问询函

Form CORRESP - Correspondence
2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/14

SEC问询函

Form CORRESP - Correspondence
2026/04/07

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/04/07

重要事件披露

Form 8-K - Current report
2026/04/03

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/30

重要事件披露

Form 8-K - Current report
2026/03/26

重要事件披露

Form 8-K - Current report
2026/03/26

SEC问询函

Form CORRESP - Correspondence
2026/03/24

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/03/24

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/03/23

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]